Scott Hobson
8Patents
2h-index
18Co-inventors
44Inventor score
Filing activity: Jul 27, 2012 → May 19, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10479794B2 | Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide | Emerging Cross-Sectional Technologies | 2 | Active |
| US10875867B2 | Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide | Emerging Cross-Sectional Technologies | 2 | Active |
| US11780827B2 | Substituted 3-phenoxyazetidin-1-yl-pyrazines | Human Necessities | 1 | Active |
| US10023575B2 | Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide | Emerging Cross-Sectional Technologies | 1 | Active |
| US11691977B2 | Cyclic ether derivatives of pyrazolo[1,5-A]pyrimidine-3-carboxyamide | Emerging Cross-Sectional Technologies | 0 | Active |
| US12351584B2 | Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide | Emerging Cross-Sectional Technologies | 0 | Active |
| US12115157B2 | 3-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives and the use thereof as medicament | Chemistry; Metallurgy | 0 | Active |
| US9206195B2 | Dihydrothienopyrimidines | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.